Pharmacovigilance definition given by WHO, it is “The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. The number of Adverse Drug Reactions (ADRs) reported, have also resulted in an increase in the volume of data handled. It is a challenge to standardize the act of signal detection and risk management in the context of clinical trials and post-marketing pharmacovigilance. However, with more clinical trials and clinical research activity being conducted in India, and also conducted in phase of clinical trials, Pharmaco epidemiologic study there is an immense need to understand and implement pharmacovigilance. This review describes the various strategies and proposals to build, maintain and implement a robust pharmacovigilance system for various take holders and eventually make it happen in India!
Cite this article:
Shraddha Anil Naik. Review on Pharmacovigilance. Asian J. Pharm. Res. 2020; 10(2):123-128. doi: 10.5958/2231-5691.2020.00024.6